Introduction
============

Infection by the cestode *Taenia solium*, a zoonotic tapeworm, exerts a considerable health and economic burden as the cause of cysticercosis in humans and pigs in endemic countries. The most acute human health burden results from neurocysticercosis-associated epilepsy, caused by cysticerci settled in the central nervous system. This disease was responsible for about 2.8 million disability-adjusted life years (DALYs) in 2010.[@R1] In the United Republic of Tanzania, the economic burden for 2012 due to neurocysticercosis-associated epilepsy, has been estimated at 5.0 million United States dollars (US\$) and the burden due to porcine cysticercosis, resulting from the reduced value of infected pork, at US\$ 2.8 million.[@R2] In Angónia district in Mozambique, with a human population of about 330 000, these estimations were about US\$ 71 000 and US\$ 22 000, respectively, in 2007.[@R3] These data highlight the impact of *T. solium* across human and animal health sectors. *T. solium* infection disproportionately affects smallholder and subsistence farming communities in endemic settings, where the presence of common risk factors, such as free-roaming pigs and poor sanitation, allows high levels of direct and indirect (environmental) disease transmission. A collaborative One Health approach, which addresses *T. solium* control from the human health, animal health and environmental perspectives, is therefore essential to tackle this zoonotic neglected tropical disease.

Tackling *T. solium*
====================

The 2012 World Health Organization (WHO) roadmap *Accelerating work to overcome the global impact of neglected tropical diseases* called for the development of a validated strategy for *T. solium* control and elimination by 2015, and for interventions to be scaled up in selected countries by 2020.[@R4] Research in 2018 on the control of *T. solium* concluded that evidence on optimal interventions for control and elimination is still limited.[@R5] A validated strategy has, therefore, not yet been identified and, hence, the 2015 target has not been met. Nevertheless, notable progress has been made,[@R5] including an elimination trial with an intensive package over a 1-year period of interventions targeting both humans and pigs on a regional scale in northern Peru.[@R6] This package included mass treatment of humans with niclosamide and pigs with oxfendazole in combination with vaccination of pigs. In addition, a more targeted ring-screening intervention, in which people within a 100-m radius of pigs found positive for cysticercosis were screened and treated for taeniasis in northern Peru, showed a significant reduction in seroincidence among pigs in the intervention village after 1 year.[@R7] Other intervention approaches are ongoing, including cost--effectiveness evaluations of both control and elimination objectives in Zambia.[@R8] *T. solium* control could also be integrated into existing water, sanitation and hygiene projects. In addition, low-cost intervention strategies could include health education tools for human health and agricultural professionals, as well as for local communities. One such tool is the Vicious Worm.[@R9] This tool has been used in the United Republic of Tanzania and Zambia to raise awareness of *T. solium* and reduce risk behaviours, such as not using latrines, improper hygiene, cooking and free-ranging pig management practices, and not seeking health care, among health-care and agricultural professionals, and schoolchildren. Computers were used in the United Republic of Tanzania, while in Zambia, the tool was projected on the wall in schools. The tool is also available as an app on smartphones with increasing numbers of people having access to such phones in sub-Saharan Africa. Studies have demonstrated a statistically significant increase in knowledge and attitudes scores in both the United Republic of Tanzania and Zambia.[@R10]^,^[@R11] In Peru, mechanisms for transferring intervention strategies to local communities, such as community-based reporting of pig cysticercosis to inform ring strategies, have also been explored.[@R12] While this study did not identify a significant change in the seroincidence of cysticercosis in the intervention group, efforts to develop locally sustainable interventions, for example, by transferring ownership of interventions, is important.

Modelling
=========

Inclusion of dynamic transmission modelling in intervention trials and programmes can add considerable value by predicting the long-term effect of extending interventions beyond the immediate scope of the trial. Currently, several transmission models exist which capture, to different degrees of complexity, the transmission dynamics of *T. solium* and which can be used to assess the effect of interventions. Recent research has characterized and compared the structures of these models, and their parameters and capabilities to model particular interventions.[@R13] Building on this research, formal comparisons of models are needed to understand the extent of the biological and epidemiological uncertainties associated with the life cycle of *T. solium* and its transmission properties in order to identify key unknown factors that would benefit from the collection of new data (further information available in the data repository)[@R14] and ultimately to build consensus on the most suitable intervention options.[@R15] Some ways to fill critical data gaps and hence improve our ability to capture baseline epidemiology in models in the absence of interventions include: better characterization of local transmission dynamics, such as force-of-infection estimates (individual rate of infection acquisition in susceptible hosts), which can be obtained from human and pig age-stratified prevalence data; risk factor analysis to improve the defining of parameters, for example, of contact rates with stages infective to humans and pigs; biological factors of adult tapeworm, for example, life span and reproductive output; and environmental factors, which will likely be highly dependent on setting, for example, egg viability studies and dispersal mechanisms to better understand the distribution of environmental contamination. Research has been conducted in Peru to understand location-specific spatial dynamics, such as clustering of cysticercosis infection in pigs around human cases of taeniasis (tapeworm infection), and seasonal drivers of transmission, which could be used to inform clear spatial and seasonal transmission models.[@R16] Further data are required to support model validation of intervention strategies, particularly longitudinal data before, during and after the intervention. To effectively incorporate field data into models, serological markers for true infection need to be identified because existing serological diagnostic methods for both human and pig infection have many limitations.

Collaboration to improve modelling
==================================

Existing *T. solium* models can be improved through collaboration between modelling groups, field epidemiologists, programme stakeholders and policy-makers, and used jointly to support the design, implementation and assessment of interventions in endemic countries. To this end, a recent workshop brought together the modelling groups for the cystiSim[@R17] and EPICYST[@R18] models and other stakeholders to work on *T. solium* modelling (further information available in the data repository).[@R14] As a result of the workshop, the CystiTeam was formed, which is a coalition of epidemiologists and programme stakeholders within the *T. solium* taeniasis and cysticercosis field. The team aims to tackle collaboratively questions on the population biology, transmission dynamics, epidemiology and control of *T. solium* through mathematical modelling approaches. [Fig. 1](#F1){ref-type="fig"} shows a pathway identifying *T. solium* modelling research priorities aimed at supporting progress towards *T. solium* control targets.[@R19] Formal model comparison research will require initial identification of similarities and differences in key structural and parametric assumptions, which has begun to be addressed by researchers.[@R13] After this step, the parameters shared between the models need to be harmonized, such as the ratio of human-to-pig population sizes, to test their influence on model outcomes, for example, stable, viable *T. solium* endemic prevalence's. Through this process, the residual differences between the models will point to important epidemiological, biological and setting-specific uncertainties that will inform the research agenda.

![Processes and outcomes for mathematical modelling priorities to tackle *Taenia solium* control and support progress in meeting control targets](BLT.19.238485-F1){#F1}

With the time fast approaching for the fulfilment of the goals set in the 2012 WHO roadmap on neglected tropical diseases, attention is refocusing on defining post-2020 targets, aligned with the Sustainable Development Goals that are relevant to neglected tropical diseases.[@R20] The expanding evidence base on interventions to control *T. solium* infection will provide new opportunities to define optimal, feasible and sustainable strategies that can use existing delivery platforms. At the same time, refinement of existing *T. solium* transmission models in a collaborative framework ([Fig. 1](#F1){ref-type="fig"}) will help to re-evaluate control goals and set realistic and attainable ones. The WHO post-2020 targets for *T. solium* are based on impact indicators for the countries with intensified control in hyperendemic areas. However, technical definitions of both intensified control and hyperendemicity need clarification for progress towards these goals over the next decade to be effectively evaluated. A key modelling activity should involve predicting, in a variety of epidemiological settings, the effect of various interventions in the currently available set of tools[@R5] through the different phases of a control to elimination programme.[@R15]

Engagement of researchers with ongoing control programmes, e.g. pilot control programme in the Antanifotsy district of Madagascar, will help evaluate the effect of interventions, both in communities that have specific taeniasis and cysticercosis interventions and in communities where anthelmintic drugs that are effective against *T. solium* are used to target other neglected tropical diseases, for example, mass administration of praziquantel for schistosomiasis. Intervention trials and control programmes will provide setting-specific data on programme parameters, such as coverage, frequency and compliance, and diagnostic performance uncertainties ([Fig. 1](#F1){ref-type="fig"}), which will help refine modelling simulations. Integrating dynamic transmission models with burden of zoonotic disease[@R21] and economic frameworks will help quantify the human health and agricultural sector gains and the cost--effectiveness of achieving newly defined global targets for zoonotic neglected tropical diseases. In northern Lao People\'s Democratic Republic, the cost--effectiveness of different intervention options was assessed.[@R22] The interventions assessed included *T. solium* taeniasis and cysticercosis control alone and in integrated programmes that incorporated classical swine fever and soil-transmitted helminth control. Such efforts could help define model parameter values for a dynamic economic analysis in an Asian context.

Model comparison, refinement, calibration and validation lies at the heart of the CystiTeam collaboration, which aims to improve confidence in the predictive capacities of mathematical and computational transmission models and raise awareness of their usefulness. The collaboration recently provided technical input to the WHO consultation on refinement of the post-2020 neglected tropical disease goal[@R20] ([Box 1](#B1){ref-type="boxed-text"} and [Table 1](#T1){ref-type="table"}; data repository).[@R14] The collaboration will bring about better engagement and dialogue between a broad spectrum of actors and stakeholders and will facilitate progress in tackling the persistent global public health and economic problems caused by *T. solium* beyond 2020. To this end, expanding this partnership to include other research groups, particularly based in Asia and Latin America, will be crucial to broaden the applicability of efforts to model *T. solium* transmission.

###### Tackling *Taenia solium* taeniasis and cysticercosis

WHO goals
---------

-   validated strategy for control of *T. solium* taeniasis and cysticercosis available by 2015

-   interventions scaled up in selected countries for *T. solium* taeniasis and cysticercosis control by 2020

2030 target
-----------

-   endemic countries (*n* = 17) with intensified control in hyperendemic areas

Is the 2030 target technically feasible with the current intervention options and tools?
----------------------------------------------------------------------------------------

-   yes, if realistic control targets are proposed

-   modelling can inform the design and evaluation of pilot and large-scale control programmes with current and complementary intervention strategies[@R8]^,^[@R13]

-   cystiSim and EPICYST, computational transmission models, are applicable;[@R17]^,^[@R18] cystiSim is already in use in Zambia and Latin America, and an additional transmission model has also been developed for Latin America[@R23]^,^[@R24]

What is required to achieve the target?
---------------------------------------

-   standardized definition of control put forward by WHO expert group

-   standardized monitoring to evaluate progress of intervention strategies

-   long-term intervention approaches to assess long-term epidemiological impact

Are current tools able to reliably measure the target?
------------------------------------------------------

-   many limitations exist with current (serological and other) diagnostic methods[@R25]

-   necropsy in pigs is the most reliable measure of infection, but limitations remain in assessment of long-term effectiveness of interventions (models can assist)

What are the biggest unknowns?
------------------------------

-   true prevalence of *T. solium* infection in humans and pigs because of poor diagnostic methods

-   adult tapeworm life span

-   effect of pig-to-people population ratio on transmission

-   processes regulating parasite acquisition in humans and pigs[@R26]

-   health and economic burden[@R2]^,^[@R3] and cost--effectiveness of interventions (DALYs likely to underestimate disease burden); possible use of the zoonotic zDALY metric[@R21]

-   linking infection to disease models, particularly to human neurocysticercosis and epilepsy[@R27]

What are the biggest risks?
---------------------------

-   long-term sustainability of interventions

DALY: disability-adjusted life year; WHO: World Health Organization.

###### Priorities, applicability of modelling, data needs and timelines for informing the 2021--2030 milestones for reduction in *Taenia solium* taeniasis and cysticercosis

  Priority issue identified in discussion with WHO                  How can modelling address this issue?                                                                                                                                                                                                                                                                                                                                                                                                                          What data are required and are they currently available?                                                                                                                                                       Next steps and likely timeline
  ----------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Identify risk areas where data and surveillance are lacking       geospatial mapping and modelling for environmental suitability analysis of likely endemic areas and populations at riskmapping of areas with suspected or probable coendemicity with other helminth infections that are being tackled with common preventive chemotherapy tools                                                                                                                                                                                proxy variables availablemore data needed -- more detailed information in regions not yet explored; updates from other areas not available                                                                     geospatial model expected to be completed by 2021 by CystiTeam members and other collaborators (funding application submitted)
  Identify the needs to start looking for potential interventions   models to predict the effect of various interventions available (e.g. cystiSim and EPICYST)                                                                                                                                                                                                                                                                                                                                                                    control pilot data (e.g. Madagascar[@R28])longitudinal data from programmes (e.g. CystiStop, Zambia[@R8]) to predict temporal trends in infection during interventionsdata from other types of interventions   control pilot data expected to be available in 2020;longitudinal intervention data expected to be available in 2020;further data to followwork planned by CystiTeam in 2019--2021
  Set thresholds for control and risk areas                         inform control targets and different thresholds; need for standardized monitoringgeospatial modelsevidence synthesis to inform policy                                                                                                                                                                                                                                                                                                                          current models can be used with available data on diagnostic sensitivity and specificity                                                                                                                       model comparison planned by CystiTeam for 2020
  Correlate with impact of schistosomiasis MDA                      adaptation of current models to simulate the added value of schistosomiasis MDA                                                                                                                                                                                                                                                                                                                                                                                epidemiological and programmatic data from co-endemic areas before and after MDA                                                                                                                               adaptation of agent-based model (CystiSim) assessed with data from Zambia[@R8] (2020)possible impact simulation with population-based and age-structured EPICYST model (2020)
  Cost--effectiveness analysis of different interventions           adaptation of current models to explore this analysiseffectiveness metrics: if DALY-based, then need to link infection model with disease model (sequelae and disability weights). DALYs likely to underestimate burden of zoonotic neglected tropical diseasescross-sectoral impact by analysing burden of disease using zoonotic (zDALYs) indicator[@R21]use of WHO FERG study on global burden of disease to calculate DALYs for all parasites considered   cost--effectiveness data on various interventions and settingscost--effectiveness studies ongoing in the fieldkey gap is link with neurocysticercosis                                                          linking *T. solium* transmission models to burden of disease frameworks being explored by CystiTeam (2019--2021)
  Best way to monitor and evaluate the impact of interventions      prevalence of cysticercosis in pigsincidence of neurocysticercosis in humans                                                                                                                                                                                                                                                                                                                                                                                   reliable necropsy data: full carcass dissection best option for pig cysticercosis, but not always possible as requires removing animals from study areas                                                       work planned by CystiTeam in 2019--2021

WHO: World Health Organization, MDA: mass drug administration, FERG: Foodborne disease burden Epidemiology Reference Group, DALY: disability-adjusted life year.

Note: The CystiTeam is a coalition of field and quantitative epidemiologists and programme stakeholders working on *T. solium* taeniasis and cysticercosis, which was recently formed to tackle collaboratively questions on population biology, transmission dynamics, epidemiology and control of *T. solium* through mathematical modelling approaches (list of contributors available in data repository).[@R14]
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